[Intensity modulated radiotherapy for intrathoracic cancers: a dangerous liaison? Our experience in the treatment of Hodgkin lymphoma mediastinal masses]

T Girinsky; M Ghalibafian; A Paumier

doi:10.1016/j.canrad.2011.06.004

[Intensity modulated radiotherapy for intrathoracic cancers: a dangerous liaison? Our experience in the treatment of Hodgkin lymphoma mediastinal masses]

Cancer Radiother. 2011 Oct;15(6-7):546-8. doi: 10.1016/j.canrad.2011.06.004. Epub 2011 Aug 31.

[Article in French]

Authors

T Girinsky¹, M Ghalibafian, A Paumier

Affiliation

¹ Département des radiations, institut de cancérologie Gustave-Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif, France. girinsky@igr.fr

PMID: 21885321
DOI: 10.1016/j.canrad.2011.06.004

Abstract

IMRT is a seducing treatment option in patients with Hodgkin lymphoma mediastinal masses due to the complex form of the tumour masses and their proximity to organs at risk such as the heart and the coronary arteries. This treatment delivery technique remains risky owing to respiratory movements and heart beats. The concomitant use of IMRT and respiratory gating is enticing, but a number of theoretical and practical hurdles remain to be resolved before it can be used in clinical daily practice.

Publication types

English Abstract
Review

MeSH terms

Academies and Institutes / statistics & numerical data
France
Hodgkin Disease / radiotherapy*
Humans
Lymphatic Irradiation / methods*
Mediastinum / radiation effects*
Myocardial Contraction
Organs at Risk
Radiation Injuries / etiology
Radiation Injuries / prevention & control
Radiotherapy, Intensity-Modulated* / adverse effects
Respiration